Turnaround

China Pharma Holdings has provided investors with preliminary insights into its performance, despite missing the official deadline for filing its...

A prominent appearance on a major financial television program on April 4, 2026, has drawn increased attention from retail investors...

Bayer faces a period of significant transition as declining revenues from its former blockbuster drugs compel urgent strategic action. The...

The German agricultural trading group BayWa is confronting a perfect storm of legal challenges and financial pressure. Beyond grappling with...

Silver Storm Mining is approaching a pivotal operational transition. The company's primary focus is the planned recommissioning of its La...

Investors in Replimune are positioning for a potential resolution to a prolonged period of uncertainty. The company's stock price advanced...

BioNTech is methodically moving beyond its pandemic legacy. A series of recent strategic decisions—from facility closures and halted trials to...

The path from a special purpose acquisition company to a fully operational public entity has proven challenging for noco-noco Inc....

Sangamo Therapeutics finds itself navigating a complex landscape of operational progress against a backdrop of challenging financial performance. Recent developments...

As the motorcycle riding season approaches, Harley-Davidson is executing a dual strategy focused on robust community engagement and firm financial...